Merkel cell carcinoma typically appears as a firm, painless, dome-shaped nodule that is red, pink, or violet in color. It grows on sun-exposed skin and can double in size in as little as five to twelve days, making it one of the fastest-growing skin cancers. Because it often resembles a cyst or benign bump, it’s frequently overlooked until it has grown significantly.
Color, Shape, and Texture
The classic Merkel cell carcinoma lesion is a shiny, firm nodule with a smooth surface. Its color ranges from flesh-toned to red to deep purple (sometimes described as “violaceous”). The skin over the nodule usually looks intact, without the crusting, ulceration, or irregular borders you might associate with other skin cancers like melanoma or squamous cell carcinoma. It can look surprisingly innocent, almost like a pimple or insect bite that simply won’t go away.
In some cases, the tumor grows deeper beneath the skin as a subcutaneous nodule with no visible color change on the surface at all. This makes it even harder to spot, since it may feel like a firm lump under otherwise normal-looking skin.
At the time of diagnosis, tumors smaller than 2 cm carry a significantly better prognosis than larger ones. That’s roughly the width of a nickel. Many people notice the lesion when it’s still small but dismiss it because it doesn’t hurt.
Where It Usually Appears
Merkel cell carcinoma overwhelmingly favors areas that get regular sun exposure. The most common location is the face, accounting for about 27% of all cases. The upper arms and shoulders come next at 22%, followed by the lower legs and hips at roughly 15%. The trunk makes up about 11% of cases, and the scalp and neck another 9%. Less common sites include the ear, eyelid, and lip.
If you’re picturing the areas of skin that see the most daylight over a lifetime, you’re picturing the typical locations for this cancer.
The AEIOU Warning Signs
Dermatologists use a five-letter checklist, AEIOU, to flag suspicious lesions. A bump that matches several of these features warrants a closer look:
- A: Asymptomatic. The lesion doesn’t itch, sting, or hurt. The lack of tenderness is itself a red flag.
- E: Expanding rapidly. Noticeable growth within three months or less.
- I: Immune suppression. The person has a weakened immune system from an organ transplant, HIV, chronic leukemia, or immunosuppressive medication.
- O: Older than 50. The vast majority of cases occur in people over age 50.
- U: UV-exposed site on fair skin. The bump sits on skin that has had significant cumulative sun exposure.
A study of 195 patients found that these five features captured the most consistent clinical characteristics at diagnosis. No single criterion is enough on its own, but a painless, fast-growing nodule on the face of a fair-skinned person over 50 should raise immediate concern.
How Fast It Grows
Speed is what sets Merkel cell carcinoma apart from most other skin cancers. Tumor doubling times have been measured at five to twelve days, and the most aggressive subtypes can double in as little as one to five days. In practical terms, a bump you first notice as pea-sized could be marble-sized within a few weeks. That rapid expansion over weeks rather than months is one of the most reliable visual clues that something is wrong.
What It’s Often Mistaken For
Because Merkel cell carcinoma doesn’t look obviously “cancerous” to most people, it’s frequently mistaken for a cyst, a benign skin growth, a lipoma (fatty lump), or even an enlarged lymph node. Its smooth surface and uniform color don’t trigger the same alarm bells as an irregularly shaped mole or a scaly patch. Even clinicians can initially misidentify it, which is one reason diagnosis is often delayed.
The key distinguishing factor is the combination of rapid growth and painlessness. A cyst that appeared last month and has already doubled in size behaves very differently from a typical benign bump.
Who Is Most at Risk
Merkel cell carcinoma is rare, with about 0.7 cases per 100,000 people per year in the United States, translating to roughly 2,500 new cases annually. But the rate has been climbing, up from 0.5 per 100,000 in 2000, largely driven by an aging population and increased sun exposure over prior decades.
Immune suppression dramatically increases risk. Organ transplant recipients face up to a 100-fold higher risk compared to the general population. People living with HIV have roughly a 13-fold increased risk. Those with chronic lymphocytic leukemia face a 7- to 10-fold increase. About 80% of Merkel cell carcinoma tumors contain DNA from a common virus called Merkel cell polyomavirus, which most people carry harmlessly but which can drive cancer in the setting of a weakened immune system or extensive UV damage.
How It’s Diagnosed
Visual inspection alone cannot confirm Merkel cell carcinoma. A skin biopsy is required, and the tissue is examined with specialized staining techniques. The most telling marker is a protein called CK20, which shows a distinctive dot-like pattern under the microscope in 89% to 100% of Merkel cell tumors. This staining pattern helps pathologists distinguish it from small-cell lung cancer, which can look similar under a microscope but stains positive for a different marker instead.
If you notice a firm, painless bump that’s growing quickly on sun-exposed skin, a biopsy is the only way to get a definitive answer.
Outlook by Stage
When Merkel cell carcinoma is caught while still localized to the skin, the prognosis is favorable. Patients with the earliest stage disease have a 95% five-year survival rate. Once the cancer has spread to distant sites, that figure drops to about 41%. The size of the original tumor matters too: tumors under 2 cm at diagnosis are associated with meaningfully better outcomes than larger ones. Early recognition of what this cancer looks like, and acting quickly when a lesion matches the pattern, is the single most important factor in long-term survival.